GELTEQ LTD (GELS:NASDAQ)
$0.4808 0.0007 (0.1458%)
Analysed GELTEQ LTD (GELS:NASDAQ) News Sources
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform
13-01-2026
yahoo.com
Gelteq announces preclinical results on medicinal cannabinoid absorption
14-01-2026
yahoo.com
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
11-02-2026
yahoo.com
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
20-03-2026
yahoo.com
Q1 Virtual Investor Summit Presentations Now Available On Demand
26-03-2026
yahoo.com
Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million
02-04-2026
yahoo.com
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth
12-05-2026
yahoo.com
Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA
14-05-2026
yahoo.com
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
20-05-2026
yahoo.com
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
04-06-2026
yahoo.com
What is the current price of GELTEQ LTD (GELS:NASDAQ)?
The current price of GELTEQ LTD (GELS:NASDAQ) is $0.4808.
GELTEQ LTD (GELS:NASDAQ) absolute price change since previous trading day?
The absolute price change of GELTEQ LTD (GELS:NASDAQ) since the previous trading day is $0.0007.
GELTEQ LTD (GELS:NASDAQ) percentage price change since previous trading day?
The percentage price change of GELTEQ LTD (GELS:NASDAQ) since the previous trading day is 0.1458%.
What is the most recent average sentiment score for GELTEQ LTD (GELS:NASDAQ)?
The most recent average sentiment score for GELTEQ LTD (GELS:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for GELTEQ LTD (GELS:NASDAQ)?
The most recent sentiment for GELTEQ LTD (GELS:NASDAQ) is .
SEC-8K** Filing Available For GELTEQ LTD (GELS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.